PTC Therapeutics, Inc. (PTCT) Debt Components
- 2026-06-30: Long-term Debt, Current MaturitiesUSD $55.45M; Long-term Debt, Excluding Current MaturitiesUSD $535.52M; Debt Instrument, Interest Rate, Effective Percentagepure 11.00%; Long-term DebtUSD (m).
- 2026-03-31: Long-term Debt, Current MaturitiesUSD $286.94M; Long-term Debt, Excluding Current MaturitiesUSD (m); Debt Instrument, Interest Rate, Effective Percentagepure 11.00%; Long-term DebtUSD (m).
- 2025-12-31: Long-term Debt, Current MaturitiesUSD $286.63M; Long-term Debt, Excluding Current MaturitiesUSD (m); Debt Instrument, Interest Rate, Effective Percentagepure (m); Long-term DebtUSD (m).
- 2025-12-31: Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Debt Instrument, Interest Rate, Effective Percentagepure 11.00%; Long-term DebtUSD (m).
PTC Therapeutics, Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Debt Instrument, Interest Rate, Effective Percentage pure | Long-term Debt USD | Debt Instrument, Convertible, Conversion Price USD/shares |
|---|---|---|---|---|---|
| 2026-06-30 | $55.45M | $535.52M | 11.00% | (m) | (m) |
| 2026-03-31 | $286.94M | (m) | 11.00% | (m) | (m) |
| 2025-12-31 | $286.63M | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | (m) | 11.00% | (m) | (m) |
| 2025-09-30 | $286.32M | (m) | 9.30% | (m) | (m) |
| 2025-06-30 | (m) | $286.01M | 9.30% | (m) | (m) |
| 2025-03-31 | (m) | $285.71M | 9.30% | (m) | (m) |
| 2024-12-31 | (m) | $285.41M | (m) | (m) | (m) |
| 2024-12-31 | (m) | (m) | 9.80% | (m) | (m) |
| 2024-09-30 | (m) | $285.11M | 9.90% | (m) | (m) |
| 2024-06-30 | (m) | $284.81M | 9.90% | (m) | (m) |
| 2024-03-31 | (m) | $284.51M | 10.80% | (m) | (m) |
| 2023-12-31 | (m) | $284.21M | (m) | (m) | (m) |
| 2023-12-31 | (m) | (m) | 10.80% | (m) | (m) |
| 2023-09-30 | (m) | $573.17M | 9.30% | (m) | (m) |
| 2023-06-30 | (m) | $572.64M | 9.70% | (m) | (m) |
| 2023-03-31 | (m) | $572.09M | 9.80% | (m) | (m) |
| 2022-12-31 | (m) | $571.72M | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | 8.70% | (m) | (m) |
| 2022-09-30 | (m) | $282.75M | 9.40% | (m) | (m) |
| 2022-06-30 | $149.91M | $282.46M | 10.10% | (m) | (m) |
| 2022-03-31 | $149.72M | $282.18M | 10.10% | (m) | (m) |
| 2021-12-31 | $149.54M | $281.89M | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | 10.90% | (m) | (m) |
| 2021-09-30 | $149.36M | $281.60M | 11.00% | (m) | (m) |
| 2021-06-30 | (m) | $430.50M | 11.50% | (m) | (m) |
| 2021-03-31 | (m) | $430.04M | 10.60% | (m) | (m) |
| 2020-12-31 | (m) | $309.14M | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | 10.40% | (m) | (m) |
| 2020-09-30 | $0.00 | $302.97M | 11.00% | (m) | 6.00 |
| 2020-07-31 | (m) | (m) | 11.00% | (m) | (m) |
| 2020-07-17 | (m) | (m) | 11.00% | (m) | (m) |
| 2020-06-30 | $18.33M | $297.03M | (m) | (m) | 6.00 |
| 2020-03-31 | $20.00M | $294.57M | (m) | (m) | 6.00 |
| 2020-01-31 | (m) | (m) | (m) | (m) | 6.00 |
| 2019-12-31 | $20.00M | $293.86M | (m) | (m) | (m) |
| 2019-09-30 | $20.00M | $293.15M | (m) | (m) | (m) |
| 2019-06-30 | $20.00M | $135.68M | (m) | (m) | (m) |
| 2019-03-31 | $16.67M | $138.47M | (m) | (m) | (m) |
| 2018-12-31 | $11.67M | $141.35M | (m) | (m) | (m) |
| 2018-09-30 | $6.67M | $144.26M | (m) | (m) | (m) |
| 2018-06-30 | $1.67M | $147.20M | (m) | (m) | (m) |
| 2018-03-31 | (m) | $146.88M | (m) | (m) | (m) |
| 2017-12-31 | $0.00 | $144.97M | (m) | (m) | (m) |
| 2017-09-30 | (m) | $143.09M | (m) | (m) | (m) |
| 2017-06-30 | (m) | $141.24M | (m) | (m) | (m) |
| 2017-03-31 | (m) | $99.89M | (m) | (m) | (m) |
| 2016-12-31 | (m) | $98.22M | (m) | (m) | (m) |
| 2016-09-30 | (m) | $96.56M | (m) | (m) | (m) |
| 2016-06-30 | (m) | $94.94M | (m) | (m) | (m) |
| 2016-03-31 | (m) | $93.37M | (m) | (m) | (m) |
| 2015-12-31 | (m) | $91.85M | (m) | (m) | (m) |
| 2015-09-30 | (m) | (m) | (m) | $93.20M | (m) |
| 2014-03-31 | $12.00K | (m) | (m) | (m) | (m) |
| 2013-12-31 | $49.00K | (m) | (m) | (m) | (m) |
| 2013-09-30 | $84.23K | (m) | (m) | (m) | (m) |
| 2013-06-30 | $2.75M | (m) | (m) | (m) | (m) |
| 2012-12-31 | $4.44M | $438.81K | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |